Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Chemotherapy With Stem Cell Rescue in Metastatic Hormone-Refractory Prostate Cancer
NCT00003400Phase 2Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Sep 1998
- Primary completion
- Mar 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carmustine, melphalan, vinorelbine, cisplatin in prostate cancer (PCa), sponsored by University of Maryland, Baltimore. Started Sep 1998; status: completed.
02
Drugs
carmustinemelphalanvinorelbinecisplatin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00003400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003400.